GLP-2 TRZ (15mg)

GLP-2 TRZ (15mg)- Product will arrive in a lyophilized (powder) form for maximum stability.

GLP-2 TRZ is a dual agonist peptide that mimics the activity of two key incretin hormones in the body: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). By activating both receptors, GLP-2 TRZ enhances insulin secretion, reduces glucagon levels, and promotes appetite regulation, offering a powerful approach to improving blood sugar control and weight management.

Unlike single incretin mimetics, GLP-2 TRZ provides a synergistic effect by targeting both GIP and GLP-1 pathways. This dual action supports greater glycemic control, improved metabolic balance, and enhanced energy regulation. Research has shown that dual agonists like GLP-2 TRZ may have superior outcomes in managing type 2 diabetes, obesity, and related metabolic disorders compared to GLP-1 agonists alone.

Beyond its primary effects on glucose metabolism and weight loss, GLP-2 TRZ is being investigated for its potential in cardiovascular health, lipid regulation, and reducing systemic inflammation. Its role in insulin sensitivity, appetite suppression, and long-term metabolic improvements makes it a promising therapeutic option in endocrinology and obesity research.